## The “$12M raise + reverse split” is really a **listing-survival financing** with a hard clock Nuburu’s latest disclosure stack reads less like a routine capital raise and more like a forced recapitalization to keep the NYSE American listing intact—because the Company is effectively constrained in how many times it can “reset” the stock via reverse splits. The Company’s preliminary proxy spells out the exchange rule constraint: after having executed a **1-for-40 reverse split on July 23, 2024**, Nuburu is **limited to implementing less than a 1-for-5 reverse stock split until July 24, 2026** (and cannot do a split ratio “at or exceed 1-for-200” within two years). ["limited to implementing less than a 1-for-5"](0001193125-26-035866|0) ["1-for-200"](0001193125-26-035866|0) **Hidden alpha “between the lines”:** this means the contemplated near-term reverse split isn’t just optics—it’s a *scarce compliance tool*. If the post-split stock re-breaks, management’s flexibility is structurally reduced, and the capital markets window narrows. ["Reverse Stock Splits… comply… continued listing standards"](0001193125-26-035866|0) --- ## The offering terms embed **significant future supply** (and a governance gate investors are underwriting) In the final prospectus (424B4), Nuburu discloses a best-efforts public offering priced at **$0.11** (pre-split), consisting of **58,379,137 shares** plus **50,711,772 pre-funded warrants**, paired with **common warrants to purchase up to 163,636,364 shares** (i.e., 150% warrant coverage). ["58,379,137 shares"](0001193125-26-053786|0) ["50,711,772 Pre-Funded Warrants"](0001193125-26-053786|0) ["warrants to purchase up to…163,636,364"](0001193125-26-053786|0) ["$0.11 per share"](0001193125-26-053786|0) The *tell* is that a portion of warrant exercisability is explicitly tied to **Stockholder Approval** tied to **authorized share capacity**—i.e., the “real” dilution is not only market-driven, it is *vote-driven*. ["subject to the Company's obtaining stockholder approval"](0001193125-26-053786|0) ["increase… authorized shares… before we can issue"](0001193125-26-053786|0) **Hidden alpha “between the lines”:** sophisticated buyers appear to be underwriting not just the raise, but the probability that Nuburu can (1) win the shareholder votes and (2) keep the listing, because the warrant package is only maximally valuable if the Company can legally and practically issue the shares. --- ## The proxy is a roadmap for **capital-structure optionality** (up to $100M), not just housekeeping The Company’s February 2026 preliminary proxy seeks approvals that, in combination, look like a deliberate attempt to create *repeatable financing capacity*: * Authority to increase authorized common shares from **900,000,000 to 2,000,000,000**. ["increase… from 900,000,000… to 2,000,000,000"](0001193125-26-035866|0) * Authority to approve issuance of up to **$100 million** of securities in one or more non-public offerings, at discounts potentially up to **30%** to market. ["up to $100 million"](0001193125-26-035866|0) ["discount of up to 30%"](0001193125-26-035866|0) * Authority to implement one or more reverse splits to support continued listing compliance. ["effect one or more reverse stock splits"](0001193125-26-035866|0) **Hidden alpha “between the lines”:** the Company is effectively asking investors to price Nuburu as a *platform-in-build mode* that will likely require multiple capital events. That can be negative if you assume indiscriminate dilution—but it can be positive if you believe management is assembling assets that can re-rate the equity faster than the float expands. --- ## The “Defense & Security platform” pivot is being funded via **asset-backed, security-heavy deals** (not just operating cash) The most recent 8‑K (dated February 6, 2026) shows Nuburu actively using structured instruments to acquire strategic assets and reduce balance-sheet pressure: * Nuburu acquired **295,000 shares (~0.8%) of Heckler & Koch AG** for **$15 million**, paid via a **subordinated convertible note** (no interest except on default; matures March 19, 2027; convertible at $0.1515 per share, with ownership caps). ["acquired…295,000 shares (or approximately 0.8%)"](0001193125-26-049000|0) ["aggregate purchase price of $15,000,000"](0001193125-26-049000|0) ["paid by Subordinated Convertible Note"](0001193125-26-049000|0) ["convertible for $0.1515 per share"](0001193125-26-049000|0) * Nuburu exchanged **844,938 shares of Series A Preferred** into treasury in return for a **pre-funded warrant** for **55,771,485 shares** (nominal exercise price), explicitly framed as part of “eliminate liabilities and return to compliance with NYSE stockholder equity requirements.” ["eliminate liabilities and return to compliance"](0001193125-26-049000|0) ["transfer of 844,938 shares"](0001193125-26-049000|0) ["55,771,485"](0001193125-26-049000|0) **Hidden alpha “between the lines”:** Nuburu is behaving like a capital-structure engineer—using convertibles, pre-funded warrants, and related-party asset acquisitions to assemble a defense/security footprint while managing equity requirements. That’s not a “steady-state operating company” playbook; it’s a *roll-up / platform construction* playbook. --- ## The risk/reward hinge: **liquidity + dilution mechanics**, not press-release momentum The Company’s own offering prospectus puts the key investor trade-off in plain sight: * The offering is **best efforts** with **no minimum** and significant dilution risk. ["best efforts"](0001193125-26-053786|0) ["no minimum amount"](0001193125-26-053786|0) * There is **no public market** expected for the pre-funded warrants or common warrants. ["no established public trading market"](0001193125-26-053786|0) * NYSE American delisting risk remains a central risk factor. ["may delist our Common Stock"](0001193125-26-053786|0) **Hidden alpha “between the lines”:** if the listing is stabilized, the Company’s financing “surface area” expands materially (registered + private channels, plus shareholder-vote-enabled issuance capacity). If it isn’t, the equity can quickly become trapped in a liquidity downgrade scenario, which the Company itself flags as a core risk. ["may delist our Common Stock"](0001193125-26-053786|0)

## The “$12M raise + reverse split” is really a **listing-survival financing** with a hard clock Nuburu’s latest disclosure stack reads less like a routine capital raise and more like a forced recapitalization to keep the NYSE American listing intact—because the Company is effectively constrained in how many times it can “reset” the stock via reverse splits. The Company’s preliminary proxy spells out the exchange rule constraint: after having executed a **1-for-40 reverse split on July 23, 2024**, Nuburu is **limited to implementing less than a 1-for-5 reverse stock split until July 24, 2026** (and cannot do a split ratio “at or exceed 1-for-200” within two years). ["limited to implementing less than a 1-for-5"](0001193125-26-035866|0) ["1-for-200"](0001193125-26-035866|0) **Hidden alpha “between the lines”:** this means the contemplated near-term reverse split isn’t just optics—it’s a *scarce compliance tool*. If the post-split stock re-breaks, management’s flexibility is structurally reduced, and the capital markets window narrows. ["Reverse Stock Splits… comply… continued listing standards"](0001193125-26-035866|0) --- ## The offering terms embed **significant future supply** (and a governance gate investors are underwriting) In the final prospectus (424B4), Nuburu discloses a best-efforts public offering priced at **$0.11** (pre-split), consisting of **58,379,137 shares** plus **50,711,772 pre-funded warrants**, paired with **common warrants to purchase up to 163,636,364 shares** (i.e., 150% warrant coverage). ["58,379,137 shares"](0001193125-26-053786|0) ["50,711,772 Pre-Funded Warrants"](0001193125-26-053786|0) ["warrants to purchase up to…163,636,364"](0001193125-26-053786|0) ["$0.11 per share"](0001193125-26-053786|0) The *tell* is that a portion of warrant exercisability is explicitly tied to **Stockholder Approval** tied to **authorized share capacity**—i.e., the “real” dilution is not only market-driven, it is *vote-driven*. ["subject to the Company's obtaining stockholder approval"](0001193125-26-053786|0) ["increase… authorized shares… before we can issue"](0001193125-26-053786|0) **Hidden alpha “between the lines”:** sophisticated buyers appear to be underwriting not just the raise, but the probability that Nuburu can (1) win the shareholder votes and (2) keep the listing, because the warrant package is only maximally valuable if the Company can legally and practically issue the shares. --- ## The proxy is a roadmap for **capital-structure optionality** (up to $100M), not just housekeeping The Company’s February 2026 preliminary proxy seeks approvals that, in combination, look like a deliberate attempt to create *repeatable financing capacity*: * Authority to increase authorized common shares from **900,000,000 to 2,000,000,000**. ["increase… from 900,000,000… to 2,000,000,000"](0001193125-26-035866|0) * Authority to approve issuance of up to **$100 million** of securities in one or more non-public offerings, at discounts potentially up to **30%** to market. ["up to $100 million"](0001193125-26-035866|0) ["discount of up to 30%"](0001193125-26-035866|0) * Authority to implement one or more reverse splits to support continued listing compliance. ["effect one or more reverse stock splits"](0001193125-26-035866|0) **Hidden alpha “between the lines”:** the Company is effectively asking investors to price Nuburu as a *platform-in-build mode* that will likely require multiple capital events. That can be negative if you assume indiscriminate dilution—but it can be positive if you believe management is assembling assets that can re-rate the equity faster than the float expands. --- ## The “Defense & Security platform” pivot is being funded via **asset-backed, security-heavy deals** (not just operating cash) The most recent 8‑K (dated February 6, 2026) shows Nuburu actively using structured instruments to acquire strategic assets and reduce balance-sheet pressure: * Nuburu acquired **295,000 shares (~0.8%) of Heckler & Koch AG** for **$15 million**, paid via a **subordinated convertible note** (no interest except on default; matures March 19, 2027; convertible at $0.1515 per share, with ownership caps). ["acquired…295,000 shares (or approximately 0.8%)"](0001193125-26-049000|0) ["aggregate purchase price of $15,000,000"](0001193125-26-049000|0) ["paid by Subordinated Convertible Note"](0001193125-26-049000|0) ["convertible for $0.1515 per share"](0001193125-26-049000|0) * Nuburu exchanged **844,938 shares of Series A Preferred** into treasury in return for a **pre-funded warrant** for **55,771,485 shares** (nominal exercise price), explicitly framed as part of “eliminate liabilities and return to compliance with NYSE stockholder equity requirements.” ["eliminate liabilities and return to compliance"](0001193125-26-049000|0) ["transfer of 844,938 shares"](0001193125-26-049000|0) ["55,771,485"](0001193125-26-049000|0) **Hidden alpha “between the lines”:** Nuburu is behaving like a capital-structure engineer—using convertibles, pre-funded warrants, and related-party asset acquisitions to assemble a defense/security footprint while managing equity requirements. That’s not a “steady-state operating company” playbook; it’s a *roll-up / platform construction* playbook. --- ## The risk/reward hinge: **liquidity + dilution mechanics**, not press-release momentum The Company’s own offering prospectus puts the key investor trade-off in plain sight: * The offering is **best efforts** with **no minimum** and significant dilution risk. ["best efforts"](0001193125-26-053786|0) ["no minimum amount"](0001193125-26-053786|0) * There is **no public market** expected for the pre-funded warrants or common warrants. ["no established public trading market"](0001193125-26-053786|0) * NYSE American delisting risk remains a central risk factor. ["may delist our Common Stock"](0001193125-26-053786|0) **Hidden alpha “between the lines”:** if the listing is stabilized, the Company’s financing “surface area” expands materially (registered + private channels, plus shareholder-vote-enabled issuance capacity). If it isn’t, the equity can quickly become trapped in a liquidity downgrade scenario, which the Company itself flags as a core risk. ["may delist our Common Stock"](0001193125-26-053786|0)